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The Role of Ultra-fast Computed Tomography in the Assessment of
Suspected or Known Coronary Artery Disease
LOUISE E J THOMSON, HARVEY D WHITE
From Green Lane Hospital, Auckland, New Zealand

The use of electron beam computed tomography
(EBCT) for non-invasive assessment of coronary artery
calcium is growing in popularity but remains
controversial. There is uncertainty regarding the place
this test has in clinical practice and the conclusions that
may or may not be drawn from test results. However, it
is clear that EBCT can be used to address defined
clinical questions regarding the presence and severity
of the atherosclerotic process. On the horizon, there is
developing potential for non-invasive coronary imaging
using new electron beam technology that may soon rival
existing multi-detector computed tomography and
coronary angiography for imaging of coronary arteries.
Frustratingly, despite continuing research in this
exciting area, there remains a paucity of evidence to
guide the application of this modality to daily clinical
practice.
The purpose of non-invasive cardiac imaging is
to address questions related to the optimal treatment of
a patient in the context of currently available therapies.
Cardiologists are challenged to identify the presence of
coronary artery disease (CAD) in symptomatic patients
without prior documented CAD (diagnostic evaluation)
and to assess the severity/risk of known CAD
(prognostic evaluation). In selected patients with cardiac
risk factors it may also be possible to identify the
presence of pre-clinical disease, that is presence of
atherosclerotic disease prior to development of
significant (>50%) epicardial disease as evaluated by
coronary angiography (screening evaluation).
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The quantification of coronary artery calcium by
EBCT is a powerful indirect marker of the total
atherosclerotic plaque burden. 1,2 It is known that
atherosclerotic plaques calcify over time, that acute
plaque rupture is related to the balance between
inflammation and mechanical stressors and that rupture
is less likely in a "stable" calcified plaque than in a noncalcified lipid rich minor plaque. The amount of calcium
burden measured by computerized tomography is
related to the likelihood of epicardial stenoses being
present.3-7 The total calcium burden in body increases
with advancing years and most men over the age of 60
have measureable levels of calcium. It has also been
shown that the observed risk of subsequent myocardial
events is increased in patients with high coronary artery
calcium scores (Figure 1).8-12 Conventional risk factors
explain very little of observed variation in calcium
scores. This finding may in part be explained by the
recent findings of the Epidemiology of Coronary Artery
Calcification (ECAC) study group who reported that
43.5% of the variation in coronary artery calcium
quantity could be attributed to genetic factors.13

Asymptomatic Patients with Risk
Factors: Screening Evaluation
Interest in the use of EBCT for screening for
atherosclerotic disease is driven by the knowledge that
large number of patients present with life threatening
cardiac events as their initial manifestation of CAD.
Currently we rely on risk factor identification and
modification in an effort to prevent or delay onset of
CAD. However, EBCT can potentially identify those
asymptomatic patients with risk factors who already
have calcifying atherosclerotic disease.
The routine use of EBCT for screening for CAD
in asymptomatic individuals was recommended against

January 2003

16

ULTRA-FAST CT IN CORONARY ARTERY DISEASE

EBCT = Electron beam computed tomography
ETT = Exercise treadmill test
MPS = Stress myocardial perfusion single photon emission computed tomography
Figure 1. Evolution of Coronary Artery Disease. In assessing the role of non-invasive imaging it is useful to remember
the natural history of coronary artery disease and the points along this time line at which various tests potentially
become abnormal. EBCT is a highly sensitive test for the presence of coronary artery calcium, however non-calcified
lipid rich plaque is inherently less stable than calcified plaque. The absence of calcium does not preclude any risk from
acute coronary events associated with abnormal risk factors and does not negate the need for risk factor modification.

by the American College of Cardiology (ACC) and
American Heart Association (AHA) expert consensus
document and Prevention Conference V, on the basis
that EBCT does not provide clear additional information
over traditional risk factor assessment. 8,14 An ideal
observational study evaluating the role of EBCT as a
test to predict outcome in asymptomatic individuals is
unlikely to be undertaken given today's knowledge of
the importance of risk factor modification and the bias
introduced by referral to catheterization on the basis of
the calcium score.

17

Studies of asymptomatic patients to date have
shown that cardiac event rates can be predicted by
coronary artery calcium scoring. Arad and associates
reported that a threshold Agatston score of 80 had an
excellent negative predictive value of 99% for prediction
of coronary events (death, MI, revascularization) in a
predominantly male population with multiple cardiac
risk factors.15 However, the positive predictive value of
EBCT at this threshold calcium score was only 10%.
This finding of high sensitivity and poor specificity is
typical of the literature in coronary artery calcium
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scoring of asymptomatic patients.8,9,15,16 In this study,
traditional risk factors remained predictive of events,
independent of the calcium score. Importantly, the
patients with lower calcium scores who had multiple
CAD risk factors remained at increased risk of events
and 7/39(18%) of the total events occurred in patients
with calcium scores <97. Thus, concern remains about
the value of EBCT as a screening test for predicting
likelihood of events in populations with multiple risk
factors and this is the population most in need of
screening.
It has been demonstrated by several studies and
in pooled analysis of data that the risk of events increases
as the coronary calcium burden increases.8,9,15 From the
multivariable analysis in Arad's paper, the odds ratio
for death, MI or revascularization increased from 14.3
to 20.2 with increasing calcium score threshold ≥80 to
≥600.
A recent publication from Wayhs et al.10 reported
an extremely high annualized event rate of 25% in a
group of 89 patients with calcium scores over 1000 who
were followed for 17±11 months. Although other studies
have found that event rates increase as calcium scores
increase, the absolute event rate observed in this
population was unusually high.
While the value of coronary calcium as an
independent predictor of patient outcome has been
demonstrated, the value of EBCT over traditional
methods of screening for the presence of CAD has not
been clearly determined. However, patient and
physician demand is such that the use of this test for
screening continues. Patients should be advised that
although event rates are low in patients with very low
calcium scores, the absence of measurable calcium does
not preclude future cardiac events and should not alter
management of cardiac risk factors. The finding of any
coronary calcium is a marker for the presence of
atherosclerosis and may serve to reinforce the need for
risk factor modification. There is anecdotal evidence
that a few asymptomatic patients with extremely high
calcium scores have had subsequent angiography on
the basis of the high score and have been found to have
left main coronary artery stenosis. From the existing
literature however, this finding is probably highly
unusual. Overall there is no evidence to support the
routine use of EBCT results in selecting therapy or guiding
referral to further testing in asymptomatic patients.
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Symptomatic Patients with Risk
Factors: Diagnostic Evaluation
The place of calcium scoring in the evaluation of
patients with risk factors and symptoms is evolving and
there is a need for longitudinal studies to help to define
where this test best fits into a testing algorithm. In
symptomatic populations, the sensitivity of calcium
scoring is again high but specificity is poor (Pooled data
sensitivity 90%, specificity 49%).8 Therefore it is likely
that the test will need to be combined with another test
in order to enhance specificity. Additionally, it is crucial
to remember that calcium scoring does not give any
information about the presence of inducible ischemia
or the left ventricular function and does not have
established value as an alternative to currently available
stress imaging techniques. Several different potential
approaches to calcium scoring in symptomatic patients
are feasible:
1. EBCT and exercise treadmill testing. The first
possible approach is to combine treadmill exercise
test results with calcium scoring in order to reduce
the rates of patients with false positive treadmill
results referred to catheterization. Shavelle and
colleagues17 found the specificity of EBCT for the
prediction of >50% angiographic stenosis was
improved from 47% to 83% by the addition of
exercise treadmill testing results to EBCT results
(Threshold Calcium score >0 and positive exercise
treadmill test). However, in this study the overall
accuracy of technetium stress was equivalent to the
EBCT/exercise treadmill test combined and
technetium stress testing was more sensitive for the
detection of flow limiting epicardial stenosis.17,18
2. EBCT and stress imaging. The second possible
approach is to send all patients with a coronary
calcium score above a threshold level to stress
imaging. Patients with calcium scores below this
threshold would receive aggressive risk factor
management and close follow up (with referral to
further testing if symptoms failed control by medical
therapy). Using this approach, patients referred for
stress imaging have a greater likelihood of significant
coronary disease. The selected threshold level of
calcium score should represent the level at which
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sensitivity is maintained, specificity increases and
the risk of future events is at an acceptably low level
for patients below the cut off to justify medical
management. The limitation of this approach,
however, is demonstrated by the fact that
approximately 4% of patients having calcium score
assessments following documented MI have no
detectable calcium. Calcium scoring gives no
information about inducible ischemia and there is
no evidence that it is superior to any existing
modality for the diagnosis of occlusive CAD.
3. EBCT and coronary angiography. This possible
approach accepts the premise that presence of
calcium represents evidence for atherosclerosis,
potentially justifying referral to coronary
catheterization to rule out significant epicardial
stenosis. Haberl and colleagues reported that absence
of calcium was associated with <1% risk of
significant CAD defined by catheterization. 6 For
detection of >50% stenosis by catheterization the
sensitivity was 99% in men and 100% in women
using a calcium score criteria of "any calcium" but
specificity was consequently very low (23% for men
and 40% for women). Therefore this approach would
subject large numbers of patients without flow
limiting lesions to an expensive invasive test that
also carries a small but significant risk. This
approach fails to recognize that calcium score by
EBCT is a marker for atherosclerosis but not
epicardial stenosis.
4. EBCT and stress imaging or coronary angiography.
A combination of the last two approaches could be
to undertake stress imaging in patients with calcium
scores up to a threshold level and direct referral to
catheterization in patients with very high calcium
scores. This approach potentially reduces rates of
unnecessary catheterization and avoids missing the
presence of ischemia in patients with low calcium
scores who have risk factors and symptoms.
5. Normal stress imaging and EBCT. The final potential
approach in the symptomatic patient is to use the
calcium score as a second-line investigation
following normal stress imaging. If a calcium score
is zero, then the physician may have increased
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confidence that there is no evidence for
atherosclerotic disease. Alternatively, an elevated
calcium score is evidence for atherosclerosis and the
patient should receive medical therapy including the
most aggressive risk factor modification.
In certain populations where exercise treadmill
testing may be considered less reliable (e.g. women)
EBCT may also potentially be an alternative to ETT in
diagnostic evaluation. The greatest role of EBCT may
be to further define risk in patients determined to be at
intermediate risk by conventional assessment of risk
factors. Currently there is inadequate published data to
determine the ideal place of EBCT in the diagnostic
algorithm. Studies of different management strategies
are needed to determine the best approach to calcium
scoring in the evaluation of symptomatic patients.

Patients with Known Coronary Artery
Disease: Prognostic Evaluation
It has been suggested that there is a potential role
for EBCT in monitoring the progression or regression
of disease in terms of plaque burden. Although early
studies reported mean inter-scan calcium score
reproducibility of only 14-38%, subsequent advances
in hardware, acquisition protocols and calcium score
calculation methods have improved aspects of
reproducibility.
It should be noted that patients with CAD are not
all suitable for EBCT evaluation of calcium scores.
Coronary artery bypass grafts calcify at a variable rate
and the use of EBCT in patients with grafts is not
recommended. In patients with known CAD, it has been
shown that calcium scores increase over time. Rates of
increase are greater in patients with occlusive coronary
artery disease and in patients with end stage renal
disease.19,20 This rate of progression slows with statin
therapy and calcium scores may even regress with
aggressive lipid lowering.21
For EBCT to be used in this context, the error of
variability at the site undertaking repeated studies must
be minimal. This variability assessment should include
assessment of inter-scan variability, intra and interobserver variability and a decision regarding the type
of calcium scoring method to be used (Agatston score
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vs calcium volume score). 22 Carefully performed
assessments using newer software systems InSight and
AccuImage have been reported excellent (>98%) inter
and intra observer reproducibility in a recently published
paper by Yamamoto et al.23 However, the overall interscan variability was marginally lower using a console
based method than the newer software and was
significantly lower for calcium volume scoring than
Agatston score (13.3% vs 17%). Importantly, inter scan
variability using the Agatston method was up to 23.9%
in patients with lower calcium scores (<66).
The routine use of calcium scoring for tracking
disease progression is not recommended. However, in
selected subsets of patients with higher calcium scores
EBCT may provide a non-invasive marker of disease
progression or regression with therapy. Evidence that
this will provide superior prognostic information to that
already available is yet to be presented.

New Horizons for Computed
Tomography in Non-invasive
Assessment of CAD
There have been developments in multi-detector
computed tomography (MDCT) that have improved
imaging times and resolution. Many centers are using
MDCT for calcium scoring as a low cost alternative to
EBCT, however there is inadequate data to show the
relationship between MDCT calcium scores and EBCT
calcium scores and the necessary validation studies are
awaited.
Coronary artery imaging using MDCT or EBCT
is a desirable addition to calcium score data. However,
until now limited temporal resolution has meant that
only the proximal portions of coronary arteries have
been clearly visualized. In the race for coronary imaging
by computed tomography, the 16-slice MDCT has
looked most promising to date in terms of temporal and
spatial resolution. In expert hands, this technology
appears accurate for the detection of significant
proximal epicardial stenosis, albeit with a moderate
radiation exposure to the patient.
General electric/Imatron claims dramatic
improvements in temporal resolution of up to 33 ms
and imaging speed of 30 frames per second with the
new "e-speed" EBCT. These advances give potential
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for EBCT to provide coronary artery imaging, cardiac
wall motion imaging and cardiac volume quantification
in addition to improved accuracy of calcium scoring.
This technology has limited availability at this point
but is a major potential advance towards a complete
non-invasive assessment of coronary artery disease risk
using EBCT. Validation studies of this latest technology
are anticipated in the near future.

Conclusion
The role of EBCT in screening, diagnosis and
prognosis continues to evolve. It has been established
that EBCT calcium scoring reflects the degree of
atherosclerotic plaque burden, that patients with
higher calcium scores are at greater risk of adverse
cardiac events and, in symptomatic patients, the
likelihood of occlusive CAD increases as a function
of calcium score.
However, enthusiastic incorporation of EBCT
into routine clinical practice should be tempered by
careful assessment of the available literature. To date,
there is no evidence that screening asymptomatic
patients provides incremental prognostic information
over established risk factors. There is additionally, a
paucity of evidence to support the use of the calcium
score as the basis for adjusting risk modification therapy
or as justification for invasive testing in asymptomatic
patients. In patients with risk factors who have had
EBCT performed and have a very high calcium score it
is appropriate to perform a test for inducible ischemia
as the next step and not to perform a coronary angiogram
based solely on the calcium score. In the diagnosis of
CAD in symptomatic patients, the low specificity of
EBCT makes it unsuitable as a stand- alone non-invasive
test but specificity can be improved by combining EBCT
with a test of inducible ischemia.
Given recent technological advances in temporal
resolution, EBCT may well play an important future
role in the management of patients with suspected
coronary artery disease. Appropriate and cost-effective
inclusion of EBCT in the assessment of patients with
suspected or known coronary artery disease will need
to follow if there is evidence that the calcium score
provides incremental or independent value over existing
techniques for diagnosis and risk assessment.
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